Revolve Robotics, an emerging leader in mobile-controlled personal robotics, today introduced Kubi, an easy-to-use robotic platform designed to vastly improve the use of Facetime, Skype, and other video calling or telepresence applications on tablet computers such as the iPad. Kubi allows remote users to "look around" the remote location during video calls by telling the robotic platform where to aim the tablet using intuitive remote controls over the Web.
Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the first implant of PARADYM RF in Canada at the Montreal Heart Institute. The PARADYMTM RF family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT-D) devices is fully supported by the recently launched SMARTVIEWTM remote monitoring system.
Preventice, Inc. announced today that its BodyGuardian Remote Patient Monitoring System (BodyGuardian RMS) will be commercially available in early 2013. Meanwhile, clinical trials are underway in the United States and Europe to quantify the impact of the BodyGuardian RMS on clinical care delivery. Preventice is demonstrating the BodyGuardian RMS this week at the mHealth Summit, one of the mobile health technology industry's leading conferences, in Washington, D.C., December 3-5, 2012.
At the 2012 mHealth Summit in Washington, D.C., Toronto-based remote health provider Ideal Life announced that it has chosen Orange Business Services to expand its remote monitoring solutions for wellness and chronic conditions to an international audience. Orange will provide seamless machine to machine (M2M) wireless connectivity for Ideal Life in Europe and Latin America, promoting comprehensive remote care to the home and preventing non-critical re-admissions of patients to hospitals.
Samsung Telecommunications America, LLC (Samsung Mobile) and Preventice™, a leading developer of mobile health solutions and remote monitoring systems, announced today that Samsung will provide mobile phones for the new BodyGuardian Remote Monitoring System (RMS)™ from Preventice. Preventice recently announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BodyGuardian RMS, allowing Preventice to market and sell BodyGuardian to hospitals and clinics for use in detecting and monitoring non-lethal cardiac arrhythmias for ambulatory patients.
ZTR™ announces the release of M50, a powerful and versatile addition to their telematics product line.
ICAP Patent Brokerage announces for auction wireless communications and home automation technologies from The Stapleton Group, Inc., which describe techniques for intruder detection security software; air monitoring, thermostat monitoring, and electrical power system load management devices for energy reduction; leak detection, bi-directional sensors, conformal repeater units and signal strength measurement devices; and animal monitoring and training methods. This portfolio will be included in the 17th ICAP Ocean Tomo IP Auction on November 29, 2012, at The Ritz Carlton in San Francisco, California.
Ball Aerospace & Technologies Corp. is part of a team selected to build the first space-based instrument to monitor major air pollutants across the North American continent for NASA's Tropospheric Emissions: Monitoring of Pollution (TEMPO) mission.
Lowe's and Verizon announced on Tuesday (Nov. 13) that customers of the home improvement retailer's Iris™ smart home solution, a 2012 CES Innovations Honoree, will now be able to use Verizon's world-class wireless network for remote monitoring and management of their homes.
Research and Markets has announced the addition of the "Telepresence Market in the US 2011-2015" report to their offering.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.